<DOC>
	<DOCNO>NCT02656706</DOCNO>
	<brief_summary>Effective adjuvant treatment increase cure patient high-risk resected melanoma . High dose interferon standard care adjuvant set highly toxic marginally effective . The combination ipilimumab nivolumab active regimen patient advance melanoma clear rationale test regimen adjuvant set . Investigators test nivolumab 3mg/kg every 2 week 1mg/kg ipilimumab every 6 week high risk adjuvant set . The duration therapy six month .</brief_summary>
	<brief_title>BrUOG 324 : Adjuvant Nivolumab Low Dose Ipilimumab Stage III Resected Stage IV Melanoma : A Phase II Brown University Oncology Research Group Trial</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Nivolumab</mesh_term>
	<criteria>Histologically cytologically proven melanoma . The primary site melanoma may cutaneous body site ocular anorectal . Documentation require send BrUOG . Completely resected stage III ( lymph node positive ) resect stage IV disease . Patients stage T4BN0 also eligible . It require patient stage IIIA disease &gt; 1mm nodal involvement via pathology assessment resect node . All patient must disease free eligible . No prior treatment melanoma surgical resection radiation . At least 4 week since prior surgery 3 week since prior radiation registration date . Age &gt; /= 18 year ECOG performance status 01 Patients must organ marrow function define within 14 day study entry : Hematologic Absolute neutrophil count ( ANC ) &gt; /= 1.5 X 109/L ; Hemoglobin &gt; /= 9.5 g/dL ; Platelets &gt; /= 100 X 109/L ; Total Bilirubin â‰¤ 1.5 x ULN except subject normal direct bilirubin know Gilbert 's syndrome . Send information BrUOG patient know Gilbert 's syndrome AST ALT &lt; /= 2.5 X ULN Albumin &gt; /= 2.5 g/dL Renal Creatinine OR Calculated creatinine clearance : Creatinine &lt; 1.5 mg/dl creatinine clearance &gt; 50ml/min No clinically significant coagulation disorder define treat MD . Therapeutic use anticoagulant permissible . Add concomitant medication log applicable . Not pregnant nursing . Women child bear potential must negative serum pregnancy test ( minimum sensitivity 25 IU/L equivalent unit HCG ) within 7 day prior Day 1 treatment . Postmenopausal woman ( surgical menopause lack menses &gt; 12 month ) need pregnancy test , please document status . Confirmation inform consent . Men woman childbearing potential enrol study must agree use adequate barrier birth control measure course study 2 month . Currently receive cancer therapy ( chemotherapy , radiation therapy , immunotherapy , biologic therapy ) investigational anticancer drug Brain metastasis , whether resect , know leptomeningeal disease know bone metastasis . Pregnant lactate female Unwillingness inability follow procedure require protocol , document Any serious uncontrolled medical disorder , opinion investigator , may increase risk associate study participation study drug administration , impair ability subject receive protocol therapy , interfere interpretation study result . Prior malignancy active within previous 2 year except locally curable cancer apparently cure , basal squamous cell skin cancer , superficial bladder cancer , carcinoma situ prostate , cervix , breast . Documentation require send BrUOG Subjects active , know suspected autoimmune disease . Subjects vitiligo , control type I diabetes mellitus , residual hypothyroidism due autoimmune condition require hormone replacement , psoriasis require systemic treatment , condition expect recur absence external trigger permit enroll . Subjects condition require systemic treatment either corticosteroid ( &gt; 10 mg daily prednisone equivalent ) immunosuppressive medication within 14 day study drug administration . Prior treatment antiPD1 , antiPDL1 antiCTLA4 antibody Any positive test result hepatitis B C virus indicate acute chronic infection Known history test positive human immunodeficiency virus know acquire immunodeficiency syndrome History severe hypersensitivity reaction monoclonal antibody . Patients unstable angina ( anginal symptom rest ) newonset angina ( begin within last 3 month ) myocardial infarction within past 6 month . History autologous transplant organ allograft even take immunosuppressive medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Adjuvant melanoma</keyword>
	<keyword>Advanced melanoma</keyword>
</DOC>